Home
Esperion

Esperion Market Share Analysis for May 2026

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Health > Biotechnology and Pharmaceuticals

Domainesperion.com

Year Founded2008

Employees201 - 500

Annual Revenue$200M - $500M

Esperion

Esperion (including company regionals)

esperion.com

See more website traffic and engagement information

Esperion Revenue up to May 2026 is 200M - 500M

revenue generated by Esperion top domains

Esperion top domains revenue over 3 years

Revenue for Esperion top domains

esperion.com200M - 500M

See more with Sales Intelligence

Total visits to Esperion's top domains

Understand Esperion market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

esperion.com16.1K

See more with Sales Intelligence

Avg. visit duration in Esperion's top domains

Analyze Esperion engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

esperion.com00:00:39

See more with Sales Intelligence

Avg. pageviews on Esperion's top domains

See how Esperion keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

esperion.com1.80

See more with Sales Intelligence

Esperion top competitors by domain

Top similar sites in May 2026, ranked by their affinity

myrbetriq.comCompany NameMyrbetriqEmployees51 - 200HQUnited States, Illinois, NorthbrookAnnual revenue$5M - $10MTotal visits22.7KHealth > Health - Other

Top technologies used by Esperion

These are the website technologies, by industry, used by Esperion top domains

Conversion & Analytics (7)

Google Analytics

Social (5)

Google+ Platform

Widget (5)

Twemoji

Marketing (4)

Google Marketing Platform

More Technologies

11

See all

News & Signals from Esperion

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEsperion - The Lipid Management Company attended event NYC Awards Night 2025 on Jan 1st '26.The Healthcare Technology Repo were honored to welcome team members from Esperion, a global biopharmaceutical company, to this year's NYC Awards Night.

NewsEsperion - The Lipid Management Company sells assets to Athyrium Capital Management, LP. in the amount of $50M.To help fund the deal, Esperion amended its credit agreement to add $25,000,000 of new term loans and entered a Royalty Purchase Agreement, selling a portion of Otsuka-related Bempedoic Acid royalties and milestones to Athyrium for $50,000,000.

NewsEsperion - The Lipid Management Company partnered with Alkem Laboratories Ltd. on Feb 17th '26.On February 17, Esperion Therapeutics Inc (NASDAQ:ESPR) struck a deal with Alkem Laboratories regarding the sale of rival generic drugs.